Jove
Visualize
联系我们

相关概念视频

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Phosphorylation01:02

Phosphorylation

50.3K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.6K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Case-malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy.

British journal of clinical pharmacology·2026
Same author

Selenium-Containing 1,4-Naphthoquinone Derivatives Trigger Reactive Oxygen Species and Apoptosis in Triple-Negative Breast Cancer Cells.

Drug development research·2026
Same author

Support from New York City's office of chief medical examiner for people bereaved by drug poisoning: development and implementation of the family support program.

Harm reduction journal·2026
Same author

British National Formulary Guidance on prescribing in pregnancy: A descriptive cross-sectional study.

British journal of clinical pharmacology·2026
Same author

Nurse led first seizure clinics-a dangerous experiment or an effective alternative to the norm?

Epilepsy & behavior : E&B·2026
Same author

Medicines prescribed in pregnancy: Protocol for a signal detection study using routinely collected data in England.

PloS one·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 6, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K

通过PP2A修饰剂改变癌症中的酸化.

Hannah Johnson1, Satya Narayan2, Arun K Sharma3

  • 1Department of Pharmacology, Penn State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.

Cancer cell international
|January 6, 2024
PubMed
概括
此摘要是机器生成的。

蛋白酸酶2A (PP2A) 对于细胞过程至关重要. 癌症中PP2A的放松调节促进瘤生长,使PP2A抑制剂和激活剂成为有前途的治疗策略.

关键词:
激活器 激活器 激活器癌症 癌症 癌症 癌症抑制剂是一种抑制剂.在PP2A中,PP2A是PP2A.治疗方法 治疗方法

更多相关视频

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.4K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

395

相关实验视频

Last Updated: Jul 6, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.4K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

395

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 在瘤学瘤学.

背景情况:

  • 蛋白酸酶2A (PP2A) 是一个关键的酸酶,调节许多细胞功能.
  • PP2A失调与癌症进展有关,导致瘤生长.
  • 针对PP2A提供了癌症治疗的治疗途径.

研究的目的:

  • 审查PP2A在癌症中的作用.
  • 讨论PP2A在癌症调节中的下游信号通路.
  • 探索PP2A激活剂和抑制剂作为抗癌剂.

主要方法:

  • 在癌症中PP2A放松调节的文献综述.
  • 分析PP2A在癌症信号通路中的作用.
  • 已知PP2A调节剂 (激活剂和抑制剂) 的汇编.

主要成果:

  • PP2A放松调节有助于瘤的进展.
  • PP2A调节器在各种癌症中表现出有效性,包括耐药类型.
  • 针对PP2A的向可以与现有的癌症疗法协同作用.

结论:

  • PP2A是癌症治疗的重要目标.
  • 通过抑制剂或激活剂调节PP2A活性,可以阻碍癌症的进展.
  • 针对PP2A的治疗有望克服耐药性并提高治疗效率.